| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 医药制造儿童类药(元) | 502,058,078.36 | 1,535,950,304.55 | 787,487,732.88 | 1,312,711,964.99 | 527,288,690.13 |
| 医药制造慢性病类药(元) | 316,847,912.45 | 770,184,610.93 | 366,901,415.63 | 789,110,687.10 | 305,081,811.68 |
| 医药其他及服务(元) | - | 19,331,720.13 | - | 61,013,736.92 | - |
| 医药制造其他类药(元) | - | - | - | 117,362,212.87 | - |
| 其他(元) | 93,618,929.17 | 177,980,368.86 | - | - | - |
| 营业成本(元) | |||||
| 医药制造儿童类药(元) | 87,967,491.13 | 221,670,438.10 | 111,559,116.14 | 150,702,809.21 | 59,124,201.93 |
| 医药制造慢性病类药(元) | 103,833,726.22 | 147,176,319.79 | 59,471,857.66 | 82,265,343.10 | 30,783,478.31 |
| 医药其他及服务(元) | - | - | - | 40,374,786.33 | - |
| 医药制造其他类药(元) | - | - | - | 26,860,673.38 | - |
| 其他(元) | 61,240,347.01 | - | - | - | - |
| 毛利(元) | |||||
| 医药制造儿童类药(元) | 414,090,587.23 | 1,314,279,866.45 | 675,928,616.74 | 1,162,009,155.78 | 468,164,488.20 |
| 医药制造慢性病类药(元) | 213,014,186.23 | 623,008,291.14 | 307,429,557.97 | 706,845,344.00 | 274,298,333.37 |
| 医药其他及服务(元) | - | - | - | 20,638,950.59 | - |
| 医药制造其他类药(元) | - | - | - | 90,501,539.49 | - |
| 其他(元) | 32,378,582.16 | - | - | - | - |
| 毛利率(%) | |||||
| 医药制造儿童类药(%) | 82.48 | 85.57 | 85.83 | 88.52 | 88.79 |
| 医药制造慢性病类药(%) | 67.23 | 80.89 | 83.79 | 89.57 | 89.91 |
| 医药其他及服务(%) | - | - | - | 33.83 | - |
| 医药制造其他类药(%) | - | - | - | 77.11 | - |
| 其他(%) | 34.59 | - | - | - | - |
| 收入构成(%) | |||||
| 医药制造儿童类药(%) | 55.02 | 61.35 | 68.22 | 57.57 | 63.35 |
| 医药制造慢性病类药(%) | 34.72 | 30.76 | 31.78 | 34.61 | 36.65 |
| 医药其他及服务(%) | - | 0.77 | - | 2.68 | - |
| 医药制造其他类药(%) | - | - | - | 5.15 | - |
| 其他(%) | 10.26 | 7.11 | - | - | - |
| 毛利构成(%) | |||||
| 医药制造儿童类药(%) | 62.79 | 67.84 | 68.74 | 58.69 | 63.06 |
| 医药制造慢性病类药(%) | 32.30 | 32.16 | 31.26 | 35.70 | 36.94 |
| 医药其他及服务(%) | - | 0.00 | - | 1.04 | - |
| 医药制造其他类药(%) | - | - | - | 4.57 | - |
| 其他(%) | 4.91 | 0.00 | - | - | - |